Integrated Analysis of HeberFERON-Driven Comparative Proteomic regulation in Glioblastoma Cells U-87MG
Dania Vázquez‐Blomquist, Vladimir Besada, Jamilet Miranda, Yassel Ramos, Sucel Palomares, Osmany Guirola, Ricardo Bringas, Eva Vonasek, Yolimar Gil, W Franco, Tamara Dı́az, Mauricio Quiñones‐Vega, Luis Javier González, Iraldo Bello Rivero
This study investigates proteomic changes in glioblastoma cells treated with HeberFERON compared to individual IFNs, identifying multitarget effects and potential pharmacodynamic biomarkers.
bioRxiv · Apr 24, 2026 · PreprintCancer Biology